Bayesian techniques for sample size determination in clinical trials: A short review

Statistical Methods in Medical Research

Volumn 12, Issue 6, 2003, Pages 489-504

  Pezeshk, Hamid ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DERMATOLOGICAL AGENT; PLACEBO;

ANALYTICAL PARAMETERS; BAYES THEOREM; CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COST; CREAM; DECISION THEORY; DRUG COST; HAIR LOSS; HUMAN; INFORMATION PROCESSING; MATHEMATICAL COMPUTING; MATHEMATICAL PARAMETERS; MEDICAL DECISION MAKING; REVIEW; SAMPLE SIZE; STATISTICAL DISTRIBUTION; VARIANCE;

BAYES THEOREM; BIOMETRY; CLINICAL TRIALS; DECISION THEORY; HUMANS; MODELS, STATISTICAL; NORMAL DISTRIBUTION; SAMPLE SIZE;

EID: 0344513174     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/0962280203sm345oa     Document Type: Review

References (34)

1. Joseph L., Bélisle P. Bayesian sample size determination for normal means and differences between normal means. The Statisticians 1997; 46: 209-26.
2. Adcock CJ. A Bayesian approach to calculating sample size for multinomial sampling. The Statistician 1987, 36: 155-59.
3. Pham-Gia T, Turkkan N. Sample size determination in Bayesian analysis. The Statistician 1992; 41: 389-92.
4. Spieglhalter DJ, Freeman LS, Parmar MKB. Bayesian approaches to randomized trials. Journal of the Royal Statistical Society A 1994; 157: 357-416.
5. Adcock CJ. Sample size determination: A review. The Statician 1997; 46: 261-83.
6. Grundy PM, Healy MJR, Rees DH. Economic choice of the amount of experimentation. Journal of the Royal Statistical Society A 1956; 18: 32-48.
7. Raiffa H, Schlaifer R. Applied Statistical Decision Theory. Cambridge, MA, USA: Harvard University Graduate, School of Business Administration, Division of Research, 1961.
8. Smith TMF. The foundation of survey sampling: A review. Journal of the Royal Statistical Society A 1976; 139: 183-95.
9. Adcock CJ. A Bayesian approach to calculating sample sizes. The Statistician 1988; 37: 433-39.
10. Adcock CJ. Bayesian approaches to the determination of sample sizes for binomial and multinomial sampling - Sonme comments on the paper by Pham-Gia and Turkkan. The Statistician 1992; 41: 399-404.
11. Adcock CJ. The Bayesian approach to the determination of sample sizes - Some comments on the paper by Joseph, Wolfson, and Berger. The Statistician 1995; 44: 155-61.
12. Joseph L, Wolfsopn DB, Du Berger R. Sample size calculations for binomial proportions via a highest posterior density intervals. Statistics in Medicine 1995; 44: 143-54.
13. Pezeshk H, Gittins JC. A fully Bayesian approach to calculating sample sizes for clinical trials with binary responses. Drug Information Journal 2002; 36: 143-50.
14. Joseph L, Du Berger R, Bélisle P. Bayesian and mixed Bayesian/likelihood criteria for sample size determination. Statistics in Medicine 1997; 16: 769-81.
15. Fraser DAS, Guttmann I. Tolerance regions. Annals of Mathematical Statistical 1956; 27: 162-79.
16. Lindley DV. The choice of sample size. The Statistician 1997; 46: 129-38.
17. Weiss R. Bayesian sample size calculations for hypothesis testing. The Statistician 1997; 46: 185-91.
18. Kass RE, Raftery AE. Bayes factors. Journal of the American Statistical Association 1995; 90: 773-95.
19. De Groot M. Probability and Statistics, 2nd edn. Addison-Wesley, 1985.
20. Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Economics 1996; 5: 513-24.
21. Morris WT. Managment Science: A Bayesian Introduction. Englewood Cliff, NJ: Prentice-Hall, 1968.
22. Pezeshk H, Gittins JC. Sample size determination in clinical trials. Student 1999; 3: 19-26.
23. Gittins JC, Pezeshk H. How large should a clinical trial be?. The Statistician 2000a; 49: 177-87.
24. Gittins JC, Pezeshk H. A behavioural Bayes method for determining the size of a clinical trial. Drug Information Journal 2000b; 34: 355-63.
25. Gittins JC, Pezeshk H. A decision theoretic approach to sample size determination in clinical trials. Journal of Biopharmaceutical Statistics 2002; 12(4): 535-51.
26. Stallard N, Thall PT, Whitehead J. Decision theoretic designs for phase II clinical trials with multiple outcomes. Biometrics 1999; 55: 971-77.
27. O'Hagan A, Stevens JW. A framework for cost-effectiveness analysis of clinical trial data. Health Economics 2001; 10: 302-15.
28. Goldstein M. A Bayesian criterion for sample size. Annals of Statistics 1981; 9: 670-72.
29. Berger JO. Statistical Decision Theory and Bayesian Analysis. New York: Springer-Verlag, 1985.
30. Spiegelhalter DJ, Freedman LS. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Statistics in Medicine 1986; 5: 1-13.
31. Gould AL. Sample sizes for event rare equivalence trials using prior information. Statistics in Medicine 1993; 12: 1209-23.
32. Hutton JL, Owens RG. Bayesian sample size calculations and prior beliefs about child sexual abuse. The Statistician 1993; 42: 399-404.
33. Rahme E, Joseph L, Gyorkos TW. Bayesian sample size determination for estimating sample size determination for estimating binomial parameters from data subject to misclassification. Applied Statistics 2000; 49: 119-28.
34. Pezeshk H. How many subjects? A Bayesian approach to the design of a clinical trial. Iranian International Journal of Science 2002; 3: 127-33.